General Information of the Protein
Protein ID
PT01920
Protein Name
Cyclin-G-associated kinase
Gene Name
GAK
Sequence
MSLLQSALDFLAGPGSLGGASGRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPITELLEQNGGYGSATLSRGPPPPVGPAGSGYSGGLALAEYDQPYGGFLDILRGGTERLFTNLKDTSSKVIQSVANYAKGDLDISYITSRIAVMSFPAEGVESALKNNIEDVRLFLDSKHPGHYAVYNLSPRTYRPSRFHNRVSECGWAARRAPHLHTLYNICRNMHAWLRQDHKNVCVVHCMDGRAASAVAVCSFLCFCRLFSTAEAAVYMFSMKRCPPGIWPSHKRYIEYMCDMVAEEPITPHSKPILVRAVVMTPVPLFSKQRSGCRPFCEVYVGDERVASTSQEYDKMRDFKIEDGKAVIPLGVTVQGDVLIVIYHARSTLGGRLQAKMASMKMFQIQFHTGFVPRNATTVKFAKYDLDACDIQEKYPDLFQVNLEVEVEPRDRPSREAPPWENSSMRGLNPKILFSSREEQQDILSKFGKPELPRQPGSTAQYDAGAGSPEAEPTDSDSPPSSSADASRFLHTLDWQEEKEAETGAENASSKESESALMEDRDESEVSDEGGSPISSEGQEPRADPEPPGLAAGLVQQDLVFEVETPAVLPEPVPQEDGVDLLGLHSEVGAGPAVPPQACKAPSSNTDLLSCLLGPPEAASQGPPEDLLSEDPLLLASPAPPLSVQSTPRGGPPAAADPFGPLLPSSGNNSQPCSNPDLFGEFLNSDSVTVPPSFPSAHSAPPPSCSADFLHLGDLPGEPSKMTASSSNPDLLGGWAAWTETAASAVAPTPATEGPLFSPGGQPAPCGSQASWTKSQNPDPFADLGDLSSGLQGSPAGFPPGGFIPKTATTPKGSSSWQTSRPPAQGASWPPQAKPPPKACTQPRPNYASNFSVIGAREERGVRAPSFAQKPKVSENDFEDLLSNQGFSSRSDKKGPKTIAEMRKQDLAKDTDPLKLKLLDWIEGKERNIRALLSTLHTVLWDGESRWTPVGMADLVAPEQVKKHYRRAVLAVHPDKAAGQPYEQHAKMIFMELNDAWSEFENQGSRPLF
    Show/Hide
Organism
Homo sapiens, Human
Protein Classification
Enzyme
>
Kinase
>
Protein Kinase
>
Other protein kinase group
>
Other protein kinase NAK family
Function
Associates with cyclin G and CDK5. Seems to act as an auxilin homolog that is involved in the uncoating of clathrin-coated vesicles by Hsc70 in non-neuronal cells. Expression oscillates slightly during the cell cycle, peaking at G1.
    Show/Hide
Uniprot ID
Primary ID:
O14976

Secondarily ID:
Q5U4P5
Q9BVY6
    Show/Hide
Ensembl ID
ENSG00000178950
HGNC ID
HGNC:4113
Subcellular Location
Cytoplasm
Perinuclear region
Golgi apparatus
Trans-Golgi network
Cell junction
Focal adhesion
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000006 , HEK293
Compound ID Compound Name Compound Formula
CP0110399
4-Anilino-3-cyanoquinoline deriv. 4
   Show/Hide
C21H21N3O5
 1
1
IC50 = 2.4 nM
   TI
   LI
   LO
   TS
CP0099872
4-Anilinoquinoline deriv. 8
   Show/Hide
C20H22N2O5
 1
1
IC50 = 23 nM
   TI
   LI
   LO
   TS
CP0569632
4-(3-ethynylanilino)-6,7-dimethoxyquinoline-3-carbonitrile
   Show/Hide
C20H15N3O2
 1
1
IC50 = 31 nM
   TI
   LI
   LO
   TS
CP0180553
6-bromo-N-(3,4,5-trimethoxyphenyl)quinolin-4-amine
   Show/Hide
C18H17BrN2O3
 1
1
IC50 = 48 nM
   TI
   LI
   LO
   TS
CP0183162
(6,7-Dimethoxy-quinazolin-4-yl)-(3-ethynyl-phenyl)-amine
   Show/Hide
C18H15N3O2
 1
1
IC50 = 72 nM
   TI
   LI
   LO
   TS
CP0289874
4-(3-Bromophenylamino)-6,7-dimethoxyquinoline-3-carbonitrile
   Show/Hide
C18H14BrN3O2
 1
1
IC50 = 130 nM
   TI
   LI
   LO
   TS
CP0245015
6-(trifluoromethyl)-N-(3,4,5-trimethoxyphenyl)quinolin-4-amine
   Show/Hide
C19H17F3N2O3
 1
1
IC50 = 170 nM
   TI
   LI
   LO
   TS
CP0011998
N-(3-bromophenyl)-6,7-dimethoxyquinazolin-4-amine
   Show/Hide
C16H14BrN3O2
 1
1
IC50 = 260 nM
   TI
   LI
   LO
   TS
CP0363886
6,7-dimethoxy-N-(3,4,5-trimethoxyphenyl)quinazolin-4-amine
   Show/Hide
C19H21N3O5
 1
1
IC50 = 350 nM
   TI
   LI
   LO
   TS
CP0036082
N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine
   Show/Hide
C22H24ClFN4O3
 1
1
IC50 = 420 nM
   TI
   LI
   LO
   TS
CP0294002
N-(3-ethynylphenyl)-6,7-dimethoxyquinolin-4-amine
   Show/Hide
C19H16N2O2
 1
1
IC50 = 500 nM
   TI
   LI
   LO
   TS
CP0438056
(3-Bromo-phenyl)-(6,7-dimethoxy-quinolin-4-yl)-amine
   Show/Hide
C17H15BrN2O2
 1
1
IC50 = 510 nM
   TI
   LI
   LO
   TS
CP0037987
N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine
   Show/Hide
C22H23N3O4
 1
1
IC50 = 910 nM
   TI
   LI
   LO
   TS
CP0402833
6,7-bis(2-methoxyethoxy)-N-(3,4,5-trimethoxyphenyl)quinazolin-4-amine
   Show/Hide
C23H29N3O7
 1
1
IC50 = 2600 nM
   TI
   LI
   LO
   TS
CP0307724
N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinolin-4-amine
   Show/Hide
C23H24N2O4
 1
1
IC50 = 4200 nM
   TI
   LI
   LO
   TS
CP0423044
N-[6-[3-[(4-fluorophenyl)methylsulfonylamino]phenyl]-1H-indazol-3-yl]cyclopropanecarboxamide
   Show/Hide
C24H21FN4O3S
 1
1
IC50 = 9240 nM
   TI
   LI
   LO
   TS
CP0489852
N-[6-[3-(propylsulfonylamino)phenyl]-1H-indazol-3-yl]cyclopropanecarboxamide
   Show/Hide
C20H22N4O3S
 1
1
IC50 = 9250 nM
   TI
   LI
   LO
   TS
CP0423041
N-[6-[3-[(3-fluorophenyl)methylsulfonylamino]phenyl]-1H-indazol-3-yl]cyclopropanecarboxamide
   Show/Hide
C24H21FN4O3S
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0423042
N-[6-[3-[[[methyl(2,2,2-trifluoroethyl)sulfamoyl]amino]methyl]phenyl]-1H-indazol-3-yl]cyclopropanecarboxamide
   Show/Hide
C21H22F3N5O3S
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0423043
N-[6-[3-[(2-methylpropylsulfonylamino)methyl]phenyl]-1H-indazol-3-yl]cyclopropanecarboxamide
   Show/Hide
C22H26N4O3S
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0423045
N-[6-[3-[(cyclopropylmethylsulfonylamino)methyl]phenyl]-1H-indazol-3-yl]cyclopropanecarboxamide
   Show/Hide
C22H24N4O3S
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0423046
N-[6-[3-(cyclopropylsulfonylamino)phenyl]-1H-indazol-3-yl]cyclopropanecarboxamide
   Show/Hide
C20H20N4O3S
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0469511
N-[6-[3-(diethylsulfamoylamino)phenyl]-1H-indazol-3-yl]cyclopropanecarboxamide
   Show/Hide
C21H25N5O3S
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0474150
N-[6-[3-[(2-fluorophenyl)methylsulfonylamino]phenyl]-1H-indazol-3-yl]cyclopropanecarboxamide
   Show/Hide
C24H21FN4O3S
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0474151
N-[6-[3-[[[ethyl(methyl)sulfamoyl]amino]methyl]phenyl]-1H-indazol-3-yl]cyclopropanecarboxamide
   Show/Hide
C21H25N5O3S
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0489853
N-[6-[3-[(3,3,3-trifluoropropylsulfonylamino)methyl]phenyl]-1H-indazol-3-yl]cyclopropanecarboxamide
   Show/Hide
C21H21F3N4O3S
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0519352
N-[6-[3-(cyclobutylsulfonylamino)phenyl]-1H-indazol-3-yl]cyclopropanecarboxamide
   Show/Hide
C21H22N4O3S
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0519634
N-[6-[3-[(2,2,2-trifluoroethylsulfonylamino)methyl]phenyl]-1H-indazol-3-yl]cyclopropanecarboxamide
   Show/Hide
C20H19F3N4O3S
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0542395
N-[6-[3-[[ethyl(methyl)sulfamoyl]amino]phenyl]-1H-indazol-3-yl]cyclopropanecarboxamide
   Show/Hide
C20H23N5O3S
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0555200
N-[6-[3-(2-methylpropylsulfonylamino)phenyl]-1H-indazol-3-yl]cyclopropanecarboxamide
   Show/Hide
C21H24N4O3S
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0555201
N-[6-[3-[(diethylsulfamoylamino)methyl]phenyl]-1H-indazol-3-yl]cyclopropanecarboxamide
   Show/Hide
C22H27N5O3S
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
Biochemical Assays
Compound ID Compound Name Compound Formula
CP0037987
N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine
   Show/Hide
C22H23N3O4
 4
1 IC50 = 38 nM
2 Kd = 3.1 nM
3 Kd = 21 nM
4 Kd = 40 nM
CP0099872
4-Anilinoquinoline deriv. 8
   Show/Hide
C20H22N2O5
 1
1 IC50 = 45 nM
CP0180553
6-bromo-N-(3,4,5-trimethoxyphenyl)quinolin-4-amine
   Show/Hide
C18H17BrN2O3
 5
1 IC50 = 200 nM
2 Kd = 1.9 nM
3 Kd = 3.1 nM
4 Kd = 4.5 nM
5 Ki = 3.1 nM
CP0245015
6-(trifluoromethyl)-N-(3,4,5-trimethoxyphenyl)quinolin-4-amine
   Show/Hide
C19H17F3N2O3
 2
1 IC50 = 210 nM
2 Kd = 31 nM
CP0036082
N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine
   Show/Hide
C22H24ClFN4O3
 2
1 Kd = 7 nM
2 Kd = 13 nM
CP0011998
N-(3-bromophenyl)-6,7-dimethoxyquinazolin-4-amine
   Show/Hide
C16H14BrN3O2
 1
1 Kd = 29 nM
Clinical Information about the Protein
Target 1 ( HUMAN cyclin G-associated kinase (GAK) )
Target Type Unknown Type Target
Disease 1 Target-related Disease  1
1 Rheumatoid arthritis [ICD-11: FA20]
Clinical Trial Drug(s) 1 Clinical Trial Drug  1
1 Baricitinib Approved
Rheumatoid arthritis